PrimeCell Bioscience, a.s. logo — Měníme klasické paradigma léčby

PrimeCell Bioscience, a.s.

Měníme klasické paradigma léčby

Founded 2007 Czech Republic Czech Republic 4 employees Biotechnology, Health Care

General Information

Company Name PrimeCell Bioscience, a.s.
Founded Year 2007
Location Czech Republic Czech Republic
Employees 4
Industries Biotechnology, Health Care
Social

BounceWatch is an independent company data service, not affiliated with PrimeCell Bioscience, a.s.. To contact PrimeCell Bioscience, a.s., visit primecell.eu.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About PrimeCell Bioscience, a.s.

PrimeCell Bioscience, a.s. is a biomedicine company located in Czech Republic that is focused on researching and clinically testing biological drugs and therapeutic technologies. The company is dedicated to altering gene and cell parameters to support the regeneration of human tissues and organs, ultimately changing the traditional paradigm of treatment. Additionally, PrimeCell Bioscience operates a technologically advanced biomedical translational center, 4Medical Innovations Ostrava, aimed at advancing innovative and regenerative medicine and optimizing the integration of basic and applied research into clinical practice. Founded in 2007, the company operates within the Biotechnology and Health Care industries, positioning itself at the forefront of regenerative medicine. Although the specific details of its last investment and the involved investors are currently undisclosed, PrimeCell Bioscience holds promising potential for venture capitalists seeking to invest in the rapidly evolving field of biomedical research and regenerative medicine. With its innovative approach and commitment to reshaping medical treatment, PrimeCell Bioscience presents an attractive opportunity for investment in the burgeoning biomedicine sector.

Taxonomy: biomedicine, regenerative medicine, stem cells, medicinal products, human cells, tissue engineering, somatic-cell therapy, cartilage replacement, cell carriers, nanomaterials, biomedical research, clinical testing, regenerative therapy, translational medicine, innovative medical technology

No funding data available for PrimeCell Bioscience, a.s. yet.

PrimeCell Bioscience, a.s. Alternatives & Competitors

PrimeCell Bioscience, a.s. vs
Aptus Bioreactors
Aptus Bioreactors United States

Regenerating Tissues, for Life

3 employees
Biotechnology, Health Care
PrimeCell Bioscience, a.s. vs

Our purpose is to build a leading, focused ATMPs company powered by advanced therapy platforms and d...

89 employees
Biotechnology, Health Care
PrimeCell Bioscience, a.s. vs

Innovation ★ Tissue Engineering ★ Cell Therapy ★ Impact

47 employees
Biotechnology, Health Care

FAQ About PrimeCell Bioscience, a.s.

Měníme klasické paradigma léčby
PrimeCell Bioscience, a.s. was founded in 2007.
PrimeCell Bioscience, a.s. is headquartered in Czech Republic.
PrimeCell Bioscience, a.s. operates in Biotechnology and Health Care. Its work centres on biomedicine, regenerative medicine, stem cells and medicinal products.
PrimeCell Bioscience, a.s. has approximately 4 employees.
Top alternatives and competitors to PrimeCell Bioscience, a.s. include Aptus Bioreactors, Stembio Cell and Tissue Technologies Inc., Bonus Biogroup, Angiocrine Bioscience, Inc., Rebirthel Co.,Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PrimeCell Bioscience, a.s. and Aptus Bioreactors are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for PrimeCell Bioscience, a.s., https://bouncewatch.com/company/primecell-bioscience-as, updated 30 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes